Cognition and behavior: Oxytocin linked to brain connections
An autism-linked variant in the receptor for oxytocin may alter connections in the brain, according to a study published 17 May in Neuroimage.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
An autism-linked variant in the receptor for oxytocin may alter connections in the brain, according to a study published 17 May in Neuroimage.
New findings identifying the targets of antibodies found in mothers of children with autism add to mounting evidence that the prenatal immune environment can alter fetal brain development, and perhaps lead to autism. Now what?
School-based interventions are arguably the best way to reach the truly underserved, under-represented and under-resourced children with autism, says Connie Kasari.
Numerous studies detail the complex challenges and the dearth of treatments that people with autism face as they mature into adulthood. Why are there so few solutions?
Ritalin lowers impulsivity, oppositional behavior and attention deficit in children with autism and has mild side effects, reports a study published 19 June in the Journal of Child and Adolescent Psychiatry.
Introducing gut bacteria to mice that lack them increases their sociability, but mainly with familiar mice, reports a study published 21 May in Molecular Psychiatry.
The majority of people lacking a functional copy of the SHANK3 gene have both autism and severe intellectual disability, according to a study published 11 June in Molecular Autism.
A new software tool detects chromosomal alterations present in only a subset of cells in the body. This method, described 31 May in BMC Genomics, may help reveal mosaicism’s contribution to neurological disorders.
A new technique to transform human stem cells into neurons is faster, more efficient and more reliable than existing methods, according to a study published 5 June in Neuron.
U.K. doctors prescribe fewer medications for autism than doctors in the U.S., perhaps due to tighter drug laws and a more conservative medical culture, suggests a new study, published 17 May in Psychopharmacology.